(Q33987096)

30 July 2017

PGE2 decreases reactivity of human platelets by activating EP2 and EP4 (English)

1 reference

30 July 2017

5

Olivier Boutaud

1 reference

30 July 2017

James P Smith

1

1 reference

30 July 2017

Elias V Haddad

series ordinal

2

1 reference

30 July 2017

Jason D Downey

series ordinal

3

1 reference

30 July 2017

Richard M Breyer

series ordinal

4

1 reference

30 July 2017

8 May 2010

1 reference

30 July 2017

1 reference

30 July 2017

126

1 reference

30 July 2017

e23-9

1 reference

30 July 2017

1

1 reference

Prostaglandin E receptors

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Cyclic 3',5'-adenosine monophosphate in human blood platelets. IV. Regulatory role of cyclic amp in platelet function

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Platelet hyperreactivity and prognosis in survivors of myocardial infarction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Physiologic role of coronary PGI2 and PGE2 in modulating coronary vascular response to sympathetic stimulation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Antagonists of the EP3 receptor for prostaglandin E2 are novel antiplatelet agents that do not prolong bleeding

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Increased bleeding tendency and decreased susceptibility to thromboembolism in mice lacking the prostaglandin E receptor subtype EP(3).

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902561

Usefulness of platelet reactivity before percutaneous coronary intervention in determining cardiac risk one year later

29 October 2018

1 reference

12 December 2020

Prostaglandin E2: effects on aggregation, shape change and cyclic AMP of rat platelets

1 reference

12 December 2020

Effects of prostaglandin E2 on human platelet adenyl cyclase and aggregation

1 reference

12 December 2020

Calcium-dependent stimulation of platelet aggregation by PGE2

1 reference

12 December 2020

On the multiplicity of platelet prostaglandin receptors I. Evaluation of competitive antagonism by aggregometry

1 reference

12 December 2020

On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs

1 reference

12 December 2020

The effects of PGE2 and CL 115,347, an antihypertensive PGE2 analogue, on human blood platelet behaviour and vascular contractility

1 reference

12 December 2020

Interactions between prostaglandin E2 and inhibitors of platelet aggregation which act through cyclic AMP

1 reference

12 December 2020

Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C

1 reference

12 December 2020

Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms

1 reference

12 December 2020

Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells

1 reference

12 December 2020

Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention

1 reference

12 December 2020

10.1016/J.THROMRES.2010.04.003

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference